Alpha Tau Medical Net Income
| DRTS Stock | USD 6.94 0.30 4.14% |
As of the 1st of February, Alpha Tau shows the Downside Deviation of 4.37, mean deviation of 3.98, and Risk Adjusted Performance of 0.1499. Alpha Tau Medical technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Alpha Tau Medical standard deviation, value at risk, as well as the relationship between the Value At Risk and kurtosis to decide if Alpha Tau Medical is priced correctly, providing market reflects its regular price of 6.94 per share. Given that Alpha Tau has jensen alpha of 1.07, we suggest you to validate Alpha Tau Medical's prevailing market performance to make sure the company can sustain itself at a future point.
Alpha Tau's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Alpha Tau's valuation are provided below:Alpha Tau Medical does not presently have any fundamental signals for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Is there potential for Biotechnology market expansion? Will Alpha introduce new products? Factors like these will boost the valuation of Alpha Tau. Projected growth potential of Alpha fundamentally drives upward valuation adjustments. Understanding fair value requires weighing current performance against future potential. All the valuation information about Alpha Tau listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Alpha Tau Medical is measured differently than its book value, which is the value of Alpha that is recorded on the company's balance sheet. Investors also form their own opinion of Alpha Tau's value that differs from its market value or its book value, called intrinsic value, which is Alpha Tau's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Alpha Tau's market value can be influenced by many factors that don't directly affect Alpha Tau's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Alpha Tau's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Alpha Tau should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Alpha Tau's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Alpha Tau 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Alpha Tau's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Alpha Tau.
| 11/03/2025 |
| 02/01/2026 |
If you would invest 0.00 in Alpha Tau on November 3, 2025 and sell it all today you would earn a total of 0.00 from holding Alpha Tau Medical or generate 0.0% return on investment in Alpha Tau over 90 days. Alpha Tau is related to or competes with Cellectis, Alto Neuroscience, Genelux Common, Larimar Therapeutics, AC Immune, DiaMedica Therapeutics, and Amarin PLC. Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercial... More
Alpha Tau Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Alpha Tau's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Alpha Tau Medical upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 4.37 | |||
| Information Ratio | 0.1871 | |||
| Maximum Drawdown | 28.89 | |||
| Value At Risk | (6.42) | |||
| Potential Upside | 10.48 |
Alpha Tau Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Alpha Tau's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Alpha Tau's standard deviation. In reality, there are many statistical measures that can use Alpha Tau historical prices to predict the future Alpha Tau's volatility.| Risk Adjusted Performance | 0.1499 | |||
| Jensen Alpha | 1.07 | |||
| Total Risk Alpha | 0.7928 | |||
| Sortino Ratio | 0.2337 | |||
| Treynor Ratio | (3.39) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Alpha Tau's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Alpha Tau February 1, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1499 | |||
| Market Risk Adjusted Performance | (3.38) | |||
| Mean Deviation | 3.98 | |||
| Semi Deviation | 3.43 | |||
| Downside Deviation | 4.37 | |||
| Coefficient Of Variation | 511.96 | |||
| Standard Deviation | 5.46 | |||
| Variance | 29.82 | |||
| Information Ratio | 0.1871 | |||
| Jensen Alpha | 1.07 | |||
| Total Risk Alpha | 0.7928 | |||
| Sortino Ratio | 0.2337 | |||
| Treynor Ratio | (3.39) | |||
| Maximum Drawdown | 28.89 | |||
| Value At Risk | (6.42) | |||
| Potential Upside | 10.48 | |||
| Downside Variance | 19.11 | |||
| Semi Variance | 11.75 | |||
| Expected Short fall | (4.70) | |||
| Skewness | 0.9368 | |||
| Kurtosis | 1.45 |
Alpha Tau Medical Backtested Returns
Alpha Tau is moderately volatile given 3 months investment horizon. Alpha Tau Medical secures Sharpe Ratio (or Efficiency) of 0.2, which signifies that the company had a 0.2 % return per unit of risk over the last 3 months. We were able to interpolate and analyze data for thirty different technical indicators, which can help you to evaluate if expected returns of 1.07% are justified by taking the suggested risk. Use Alpha Tau Risk Adjusted Performance of 0.1499, mean deviation of 3.98, and Downside Deviation of 4.37 to evaluate company specific risk that cannot be diversified away. Alpha Tau holds a performance score of 15 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of -0.31, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Alpha Tau are expected to decrease at a much lower rate. During the bear market, Alpha Tau is likely to outperform the market. Use Alpha Tau value at risk, as well as the relationship between the kurtosis and market facilitation index , to analyze future returns on Alpha Tau.
Auto-correlation | 0.37 |
Below average predictability
Alpha Tau Medical has below average predictability. Overlapping area represents the amount of predictability between Alpha Tau time series from 3rd of November 2025 to 18th of December 2025 and 18th of December 2025 to 1st of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Alpha Tau Medical price movement. The serial correlation of 0.37 indicates that just about 37.0% of current Alpha Tau price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.37 | |
| Spearman Rank Test | 0.25 | |
| Residual Average | 0.0 | |
| Price Variance | 0.99 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Alpha Tau Medical reported net income of (31.75 Million). This is 109.3% lower than that of the Biotechnology sector and 145.33% lower than that of the Health Care industry. The net income for all United States stocks is 105.56% higher than that of the company.
Alpha Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Alpha Tau's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Alpha Tau could also be used in its relative valuation, which is a method of valuing Alpha Tau by comparing valuation metrics of similar companies.Alpha Tau is currently under evaluation in net income category among its peers.
Alpha Fundamentals
| Return On Equity | -0.54 | ||||
| Return On Asset | -0.26 | ||||
| Current Valuation | 558.6 M | ||||
| Shares Outstanding | 85.26 M | ||||
| Shares Owned By Insiders | 32.70 % | ||||
| Shares Owned By Institutions | 3.12 % | ||||
| Number Of Shares Shorted | 527.36 K | ||||
| Price To Book | 7.63 X | ||||
| EBITDA | (30.3 M) | ||||
| Net Income | (31.75 M) | ||||
| Cash And Equivalents | 112.04 M | ||||
| Cash Per Share | 1.63 X | ||||
| Total Debt | 12.54 M | ||||
| Current Ratio | 41.98 X | ||||
| Book Value Per Share | 0.91 X | ||||
| Cash Flow From Operations | (19.78 M) | ||||
| Short Ratio | 1.54 X | ||||
| Earnings Per Share | (0.52) X | ||||
| Target Price | 8.25 | ||||
| Number Of Employees | 125 | ||||
| Beta | 1.04 | ||||
| Market Capitalization | 591.73 M | ||||
| Total Asset | 86.2 M | ||||
| Retained Earnings | (147.51 M) | ||||
| Working Capital | 55.55 M | ||||
| Net Asset | 86.2 M |
About Alpha Tau Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Alpha Tau Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Alpha Tau using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Alpha Tau Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Alpha Stock Analysis
When running Alpha Tau's price analysis, check to measure Alpha Tau's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alpha Tau is operating at the current time. Most of Alpha Tau's value examination focuses on studying past and present price action to predict the probability of Alpha Tau's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alpha Tau's price. Additionally, you may evaluate how the addition of Alpha Tau to your portfolios can decrease your overall portfolio volatility.